Nav: Home

Fruit flies could be key to fighting cervical cancer caused by human papillomavirus

August 18, 2016

Human papillomavirus (HPV) is one of the most common sexually transmitted infections in the United States and has been identified as a primary cause of cervical cancer in women. Now, an international team of researchers led by the University of Missouri has completed studies on fruit flies with a condition that mimics a form of HPV-induced cancer. The fly models the team developed may help scientists understand the underlying mechanism by which this virus can cause cancer as well as identify potential drug treatments. The study appears in today's issue of PLoS Pathogens.

"This is the first model of an HPV-induced cancer in fruit flies," said Bing Zhang, professor of biological sciences in the MU College of Arts and Science and a corresponding author of the study. "This new model will help scientists understand the molecular and biochemical pathways involved in tumor growth and malignancy caused by HPV as well as screen for potential drug targets."

Previous studies conducted in human cells and in mice have shown that the virus enters the body through the skin and produces several oncoproteins, which are proteins that can transform a normal cell into a tumor cell. One of these viral oncoproteins, called E6, plays an important role during the later stages of tumor formation and metastasis.

In the study, led by Mojgan Padash, a postdoctoral fellow at the University of Missouri, the researchers introduced the viral E6 oncoprotein and a human protein that is necessary for E6-induced cancer into fruit flies. The proteins caused severe abnormalities in the epithelial, or skin, cells of the fruit flies. The researchers also show reduced levels of the same suite of proteins targeted by E6 in humans. Further experiments done in human cell lines with the fruit fly version of the E6-targeted proteins yielded similar results, providing additional evidence that E6 works the same in flies as it does in humans.

Although cellular abnormalities resulted, the scientists found that the E6 proteins were not sufficient enough to cause tumors in flies. Since it is thought that mutations in a human oncoprotein, called Ras, may contribute to E6-mediated tumor development in humans, the researchers introduced this third protein into the flies. With all three proteins present, the flies developed malignant tumors that metastasized.

"The take home message is that the same key molecular players that underlie HPV E6-mediated cancer in humans do the same things in flies," Padash said. "Practically speaking, this means we can now use this fly model to identify other essential components that contribute to E6-mediated tumorigenesis, which has the potential to translate into therapies for HPV-induced cancers."

"The model that has been developed has been used to identify other essential pathways that contribute to E6-driven malignancy," said Lawrence Banks, head of the Tumor Virology group at the International Centre for Genetic Engineering and Biotechnology in Trieste, Italy, and a coauthor of the study. "The power of this model is that it can be used now to screen for inhibitors of other pathways, which have the potential to translate into therapies for HPV-induced cancer."
-end-
The study, "A Drosophila model of HPV E6-1 induced malignancy reveals essential roles for Magi and the insulin receptor," was supported by grants from the National Institutes of Health (RO1NS060878), the University of Missouri, the Canadian Institutes of Health Research (MOP-123420) and the Italian Association for Cancer Research. The work was performed in collaboration with Vanessa Auld, professor of zoology at the University of British Columbia in Canada, and Lawrence Banks, group leader of tumour virology at the International Centre for Genetic Engineering and Biotechnology in Italy. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency.

Editor's note: For more on the story, please see: http://biology.missouri.edu/news/new-fruit-fly-model-may-yield-new-clues-drug-treatments-for-cervical-cancer/

University of Missouri-Columbia

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.